Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 378
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2227DCP, (cut-off value of 86 mAU/mL)ProteinHumanDCP upregulated in HCC DiagnosticHCC v/s Normal p < 0.001Serum25382443
2228AFPProteinHumanAFP upregulated in HCC DiagnosticHCC v/s Non-HCC p < 0.001Serum29163838
2229DCPProteinHumanDCP upregulated in HCC DiagnosticHCC v/s Non-HCC p < 0.001Serum29163838
2230AFP, DCP, (DCP >40 mAU/mL, AFP >20 ng/mL)ProteinHumanAFP and DCP upregulated in HCC DiagnosticHCC v/s Non-HCC p < 0.001Serum29163838
2231TP73-AS1LncRNAHumanUpregulated in HCC (with more than 2 fold change) Diagnostic and PrognosticHCC v/s Normal; associated with worse clinicopathological features, poorer prognosis and shorter survival p < 0.001Tissue28403886
2232CCAT2LncRNAHumanUpregulated in HCC DiagnosticHCC v/s Normal p < 0.05Tissue27347113
2233UCA1LncRNAHumanUpregulated in HCC DiagnosticHCC v/s Normal p < 0.05Tissue28271214
2236MALAT1LncRNAHuman, Mice and cell linesUpregulated in HCC with Fold change=3.233 DiagnosticHCC v/s Normal p < 0.05Tissue27993818
2237ANRILLncRNAHumanUpregulated in HCC with Fold change >1.0 DiagnosticHCC v/s Normal p < 0.01Tissue25966845
2240lncRNA-hPVT1LncRNAHumanUpregulated in HCC and higher hPVT1 expression levels in HCC tissues significantly correlated with markedly reduced recurrence-free survival Diagnostic and PrognosticHCC v/s Normal; associated with recurrence and survival in patients p < 0.001Tissue25043274
2241DANCRLncRNAHumanUpregulated in HCC Diagnostic and PrognosticHCC v/s Normal/Cirrhosis/CHB;associated with metastasis of patients p < 0.001Plasma27919960
2242RP11-160H22.5LncRNAHumanUpregulated in HCC with Fold change >2.0 DiagnosticHCC v/s Normal p < 0.01Plasma25714016
2243XLOC_014172LncRNAHumanUpregulated in HCC with Fold change >2.1 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016
2244LOC149086LncRNAHumanUpregulated in HCC with Fold change >2.0 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016
2245RP11-160H22.5, XLOC_014172, LOC149086LncRNAHumanUpregulated in HCC with Fold change >2.0 Diagnostic and PrognosticHCC v/s Normal; associated with metastatsis of patients p < 0.01Plasma25714016
2246HLA-CRNAsHumanUpregulated in HCC and CHC v/s normal (with 67 fold change) DiagnosticHCC and CHC v/s normal p < 0.01Tissue11401510
2247B2MRNAsHumanUpregulated in HCC and CHC v/s normal (with 67 fold change) DiagnosticHCC and CHC v/s normal p < 0.01Tissue11401510
2248BR1RNAsHumanUpregulated in HCC and CHC v/s normal (with 19 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2249GPC3RNAsHumanUpregulated in HCC than CHC and normal (with nearly 15 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2250UBDRNAsHumanUpregulated in HCC than CHC and normal (with nearly 12 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2251CXCL10RNAsHumanUpregulated in HCC than CHC and normal (with nearly 13 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2252CYP3A4RNAsHumanDownregulated in HCC than CHC and normal (with nearly 42 and 50 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2253CYP4A11RNAsHumanDownregulated in HCC than CHC and normal (with nearly 17 and 30 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2254SLC22A1RNAsHumanDownregulated in HCC than CHC and normal (with nearly 8 and 17 fold change) DiagnosticHCC v/s CHC and normal p < 0.01Tissue11401510
2255Enoyl-CoA hydrataseProteinHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue15221772
2256Tropomyosin-beta-chainProteinHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.01Tissue15221772
2257KetohexokinaseProteinHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.01Tissue15221772
2258Liver type aldolaseProteinHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue15221772
2259Arginase 1ProteinHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.01Tissue15221772
2260CDK4RNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2261BaxRNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2262NOTCH4RNAsHumanUpregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2263ISGF3GRNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2264TNFRNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2265VISARNAsHumanDownregulated Diagnostic and prognosticHCC with Cirrhosis v/s HCC without Cirrhosis p < 0.05Tissue18959789
2267SPP1RNAs and ProteinHumanUpregulated in PT than PN (with 3 fold change) DiagnosticMetastatic HCC v/s Primary HCC p < 0.01Tissue12640447
2268LIMK1, CENPE, FZD2, ENO2, ITGA9, COPA, KIAA0660, GTF2H1, VPS41, RGS20, MATK, STOML1, BASP1, EPB42, ALDH3B2, MEL, CAT56, RAB3A, PSCD3, PLD2, ADCYAP1R1, ALDH3B1, RHD, CSF3R, KIAA0063, KIAA0296, LRP6, ENO3, CTRB1, YES1, IncytePD:1404153, GYS1, MDFI, GABRE, IncytePD:2685601, CD3Z, DTYMK, SPTBN2, IncytePRNAsHumanUpregulated in PT than PN (with 3 fold change) DiagnosticMetastatic HCC v/s Primary HCC p < 0.01Tissue12640447
2292RPS5RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 6.35) and (v/s HCV associated HCC with ratio of 2.38) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2293KRT8RNAsHumanUpregulated in HBV associated HCC ( v/s normal with fold change 5.68) and (v/s HCV associated HCC with ratio 3.19) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2294CFLARRNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 2.86) and (v/s HCV associated HCC with ratio of 2.09) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2295ATP5F1RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 4.19) and (v/s HCV associated HCC with ratio of 3.52) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2296IGFBP2RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 3.37) and (v/s HCV associated HCC with ratio of 2.49) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2297MAP3K5RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 3.76) and (v/s HCV associated HCC with ratio of 2.33) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2298MMP9RNAsHumanUpregulated in HBV associated HCC (v/s normal samples with fold change 7.43) and (v/s HCV associated HCC with ratio of 3.74) DiagnosticHBV associated HCC v/s normal and HCV associated HCC p < 0.05Tissue18932288
2299VIMRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 8.61) and (ratio of HBV-HCC v/s HCV-HCC 0.28) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2300ACTBRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 4.13) and (ratio of HBV-HCC v/s HCV-HCC 0.37) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2301GAPDRNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 5.27) and (ratio of HBV-HCC v/s HCV-HCC 0.29) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2302CD58RNAsHumanUpregulated in HCV associated HCC (v/s normal samples with fold change 4.68) and (ratio of HBV-HCC v/s HCV-HCC 0.31) DiagnosticHCV associated HCC v/s normal and HBV associated HCC p < 0.05Tissue18932288
2304CLDN10RNAsHumanUpregulated in Cirrhosis v/s control and early and advanced HCC DiagnosticCirrhosis v/s Low/High grade dysplastic nodules, normal and early/Late HCC p < 0.05Tissue17393520
2305GREM2RNAsHumanUpregulated in dysplasia v/s control and early/advanced HCC Diagnosticdysplasia v/s early/late HCC and normal p < 0.05Tissue17393520

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top